Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins
US-10669323-B2 · Jun 2, 2020 · US
Hamamatsu Norio was listed as an assignee on 1 patent publication in 2020.
| Metric | Value |
|---|---|
| Company | Hamamatsu Norio |
| Year | 2020 |
| Patents | 1 |
Representative publications for Hamamatsu Norio in 2020.
Most common classification codes for Hamamatsu Norio in 2020.
Navigate to parent entity pages.